Huang et al. developed an AI-assisted framework for HER2 scoring in urothelial carcinoma, demonstrating how computational methods can resolve diagnostic ambiguities arising from heterogeneous membrane expression [48]. This evidence concerns the gene ERBB2 and urothelial carcinoma.